Co-SLD suppressed the growth of oral squamous cell carcinoma via disrupting mitochondrial function

Reference

• Starmer HM, Abrams R, Webster K, et al. Feasibility of a mobile application to enhance swallowing therapy for patients undergoing radiation-based treatment for head and neck cancer. Dysphagia. 2018;33:227–233.
   PubMed Web of Science ®Google Scholar
• Ferris RL, Blumenschein G, Jr., Fayette J, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med. 2016;375:1856–1867.
   PubMed Web of Science ®Google Scholar
• Price KA, Cohen EE. Current treatment options for metastatic head and neck cancer. Curr Treat Options Oncol. 2012;13:35–46.
   PubMed Web of Science ®Google Scholar
• Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clinic Procee. 2016;91:386–396.
   PubMed Web of Science ®Google Scholar
• Petre A, Dalban C, Karabajakian A, et al. Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule. Oncotarget. 2018;9:22038–22046.
   PubMedGoogle Scholar
• Dubot C, Bernard V, Sablin MP, et al. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival. Eur. J. Cancer. 2018;91:47–55.
   PubMed Web of Science ®Google Scholar
• Sacco AG, Cohen EE. Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma. JCO. 2015;33:3305–3313.
   PubMed Web of Science ®Google Scholar
• Law BYK, Qu YQ, Mok SWF, et al. New perspectives of cobalt tris(bipyridine) system: anti-cancer effect and its collateral sensitivity towards multidrug-resistant (MDR) cancers. Oncotarget. 2017;8:55003–55021.
   PubMedGoogle Scholar
• Kartal-Yandim M, Adan-Gokbulut A, Baran Y. Molecular mechanisms of drug resistance and its reversal in cancer. Crit. Rev. Biotechnol. 2016;36:716–726.
   PubMed Web of Science ®Google Scholar
• Wu Q, Yang Z, Nie Y, et al. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. Cancer Lett. 2014;347:159–166.
   PubMed Web of Science ®Google Scholar
• Paunescu E, McArthur S, Soudani M, et al. Nonsteroidal anti-inflammatory-organometallic anticancer compounds. Inorg. Chem. 2016;55:1788–1808.
   PubMed Web of Science ®Google Scholar
• Ndagi U, Mhlongo N, Soliman M. E. Metal complexes in cancer therapy - an update from drug design perspective. Drug Des Devel Ther. 2017;11:599–616.
   PubMed Web of Science ®Google Scholar
• Banti C. N, Giannoulis A. D, Kourkoumelis N, et al. Novel metallo-therapeutics of the NSAID naproxen. Interaction with intracellular components that leads the cells to apoptosis. Dalton Trans. 2014;43:6848–6863.
   PubMed Web of Science ®Google Scholar
• Nagababu P, Barui AK, Thulasiram B, et al. Antiangiogenic activity of mononuclear copper(II) polypyridyl complexes for the treatment of cancers. J Med Chem. 2015;58:5226–5241.
   PubMed Web of Science ®Google Scholar
• Dam J, Ismail Z, Kurebwa T, et al. Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity. Eur J Medicinal Chem. 2017;126:353–368.
   PubMed Web of Science ®Google Scholar
• Prathima B, Rao YS, Ramesh GN, et al. Synthesis, spectral characterization and biological activities of Mn(II) and Co(II) complexes with benzyloxybenzaldehyde-4-phenyl-3-thiosemicarbazone. Spectrochimica Acta A Mol Biomol Spectro. 2011;79:39–44.
   PubMed Web of Science ®Google Scholar
• Tabrizi L, Talaie F, Chiniforoshan H. Copper(II), cobalt(II) and nickel(II) complexes of lapachol: synthesis, DNA interaction, and cytotoxicity. J Biomol Struct Dynamics. 2017;35:3330–3341.
   PubMed Web of Science ®Google Scholar
• Kastl A, Wilbuer A, Merkel AL, et al. Dual anticancer activity in a single compound: visible-light-induced apoptosis by an antiangiogenic iridium complex. Chem. Communic (Cambridge, England). 2012;48:1863–1865.
   PubMed Web of Science ®Google Scholar
• Munteanu CR, Suntharalingam K. Advances in cobalt complexes as anticancer agents. Dalton Trans. 2015;44:13796–13808.
   PubMed Web of Science ®Google Scholar
• Tsukiji N, Osada M, Sasaki T, et al. Cobalt hematoporphyrin inhibits CLEC-2-podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice. Blood Adv. 2018;2:2214–2225.
   PubMed Web of Science ®Google Scholar
• King AP, Gellineau HA, Ahn JE, et al. Bis(thiosemicarbazone) complexes of cobalt(III). Inorg Chem. 2017;56:6609–6623.
   PubMed Web of Science ®Google Scholar
• Thamilarasan V, Sengottuvelan N, Sudha A, et al. Cobalt(III) complexes as potential anticancer agents: physicochemical, structural, cytotoxic activity and DNA/protein interactions. J Photochemist Photobiol. 2016;162:558–569.
   PubMed Web of Science ®Google Scholar
• Vignesh G, Pradeep I, Arunachalam S, et al. Biological and protein-binding studies of newly synthesized polymer-cobalt(III) complexes. Luminescence. 2016;31:533–543
   PubMed Web of Science ®Google Scholar
• Schimler SD, Hall DJ, Debbert SL. Anticancer (hexacarbonyldicobalt)propargyl aryl ethers: synthesis, antiproliferative activity, apoptosis induction, and effect on cellular oxidative stress. J Inorganic Biochem. 2013;119:28–37.
   PubMed Web of Science ®Google Scholar
• Schmidt K, Jung M, Keilitz R, et al. Acetylenehexacarbonyldicobalt complexes, a novel class of antitumor drugs. Inorganica Chimica Acta. 2000;306:6–16.
   Web of Science ®Google Scholar
• Qin QP, Qin JL, Meng T, et al. High in vivo antitumor activity of cobalt oxoisoaporphine complexes by targeting G-quadruplex DNA, telomerase and disrupting mitochondrial functions. Eur J Med Chem. 2016;124:380–392.
   PubMed Web of Science ®Google Scholar
• Sawle P, Foresti R, Mann BE, et al. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol. 2005;145:800–810.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Hewett PW, Fujisawa T, et al. Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation. Thromb Haemost. 2015;113:329–337.
   PubMed Web of Science ®Google Scholar
• Wegiel B, Gallo D, Csizmadia E, et al. Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth. Cancer Res. 2013;73:7009–7021.
   PubMed Web of Science ®Google Scholar
• Simon T, Anegon I, Blancou P. Heme oxygenase and carbon monoxide as an immunotherapeutic approach in transplantation and cancer. Immunotherapy 2011;3:15–18.
   PubMed Web of Science ®Google Scholar
• Gong YG, Zhang TF, Li M, et al. Toxicology and bioactivities of CO-releasing molecules based on cobalt complexes. Yao Xue Xue Bao = Acta Pharmaceutica Sinica 2016;51:425–433.
   PubMedGoogle Scholar
• Byatnal AA, Byatnal A, Sen S, et al. Cyclooxygenase-2–an imperative prognostic biomarker in oral squamous cell carcinoma–an immunohistochemical study. Pathol Oncol Res. 2015;21:1123–1131.
   PubMed Web of Science ®Google Scholar
• Yin T, Wang G, Ye T, et al. Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator. Sci Rep. 2016;6:19534.
   PubMed Web of Science ®Google Scholar
• Obermoser V, Baecker D, Schuster C, et al. Chlorinated cobalt alkyne complexes derived from acetylsalicylic acid as new specific antitumor agents. Dalton Trans. 2018;47:4341–4351.
   PubMed Web of Science ®Google Scholar
• Yang B, Jia L, Guo Q, et al. Clinicopathological and prognostic significance of cyclooxygenase-2 expression in head and neck cancer: a meta-analysis. Oncotarget 2016;7:47265–47277.
   PubMedGoogle Scholar
• Sudbo J, Ristimaki A, Sondresen JE, et al. Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions. Oral Oncol. 2003;39:497–505.
   PubMed Web of Science ®Google Scholar
• St John MA. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma. Laryngoscope. 2015;125:S1–S11.
   PubMed Web of Science ®Google Scholar
• Janakiraman H, House RP, Talwar S, et al. Repression of caspase-3 and RNA-binding protein HuR cleavage by cyclooxygenase-2 promotes drug resistance in oral squamous cell carcinoma. Oncogene 2017;36:3137–3148.
   PubMed Web of Science ®Google Scholar
• Siebel AM, Vianna MR, Bonan CD. Pharmacological and toxicological effects of lithium in zebrafish. ACS Chem Neurosci. 2014;5:468–476.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang J, Zhang Q, et al. Synthesis and biological activities of carbonyl cobalt CORMs with selectively inhibiting cyclooxygenase-2. J Organomet Chem. 2018;874:49–62.
   Web of Science ®Google Scholar
• Gong Y, Zhang T, Li M, et al. Toxicity, bio-distribution and metabolism of CO-releasing molecules based on cobalt. Free Radical Biol Med. 2016;97:362–374.
   PubMed Web of Science ®Google Scholar
• Si J, Zhou R, Zhao B, et al. Effects of ionizing radiation and HLY78 on the zebrafish embryonic developmental toxicity. Toxicology 2019;411:143–153.
   PubMed Web of Science ®Google Scholar
• McGrath P, Li CQ. Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today. 2008;13:394–401.
   PubMed Web of Science ®Google Scholar
• Zhao L, Si J, Wei Y, et al. Toxicity of porcelain-fused-to-metal substrate to zebrafish (Danio rerio) embryos and larvae. Life Sci. 2018;203:66–71.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yan J, Sun C, et al. Ameliorating mitochondrial dysfunction restores carbon ion-induced cognitive deficits via co-activation of NRF2 and PINK1 signaling pathway. Redox Biol. 2018;17:143–157.
   PubMed Web of Science ®Google Scholar
• Zhou R, Zhang H, Wang Z, et al. The developmental toxicity and apoptosis in zebrafish eyes induced by carbon-ion irradiation. Life Sci. 2015;139:114–122.
   PubMed Web of Science ®Google Scholar
• Sun C, Wang Z, Liu Y, et al. Carbon ion beams induce hepatoma cell death by NADPH oxidase-mediated mitochondrial damage. J Cellular Physiol. 2014;229:100–107.
   PubMed Web of Science ®Google Scholar
• Sun C, Liu X, Di C, et al. MitoQ regulates autophagy by inducing a pseudo-mitochondrial membrane potential. Autophagy 2017;13:730–738.
   PubMed Web of Science ®Google Scholar
• Wang P, Liu H, Zhao Q, et al. Syntheses and evaluation of drug-like properties of CO-releasing molecules containing ruthenium and group 6 metal. Eur J Med Chem. 2014;74:199–215.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang J, Zhang Q, et al. Syntheses and anti-cancer activity of CO-releasing molecules with targeting galactose receptors. Org Biomol Chem. 2018;16:8115–8129.
   PubMed Web of Science ®Google Scholar
• Sipes NS, Padilla S, Knudsen TB. Zebrafish: as an integrative model for twenty-first century toxicity testing. Birth Defects Res C Embryo Today Rev. 2011;93:256–267.
   PubMed Web of Science ®Google Scholar
• Cai G, Zhu J, Shen C, et al. The effects of cobalt on the development, oxidative stress, and apoptosis in zebrafish embryos. Biol Trace Elem Res. 2012;150:200–207.
   PubMed Web of Science ®Google Scholar
• Reinardy HC, Syrett JR, Jeffree RA, et al. Cobalt-induced genotoxicity in male zebrafish (Danio rerio), with implications for reproduction and expression of DNA repair genes. Aquat Toxicol. 2013;126:224–230.
   PubMed Web of Science ®Google Scholar
• Song JE, Si J, Zhou R, et al. Effects of exogenous carbon monoxide releasing molecules on the development of zebrafish embryos and larvae. Biomed Environ Sci. 2016;29:453–456.
   PubMed Web of Science ®Google Scholar
• Zhou R, Song J, Si J, et al. Effects of Ru(CO)3Cl-glycinate on the developmental toxicities induced by X-ray and carbon-ion irradiation in zebrafish embryos. Mutat Res. 2016;793-794:41–50.
   PubMed Web of Science ®Google Scholar
• Glickman NS, Yelon D. Cardiac development in zebrafish: coordination of form and function. Sem Cell Dev Biol. 2002;13:507–513.
   PubMed Web of Science ®Google Scholar
• Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495–516.
   PubMed Web of Science ®Google Scholar
• Tucker B, Lardelli M. A rapid apoptosis assay measuring relative acridine orange fluorescence in zebrafish embryos. Zebrafish 2007;4:113–116.
   PubMed Web of Science ®Google Scholar
• Mathieu C, Meier P, Meyer zu Starten A, et al. [Do selective COX-2 inhibitors have adverse renal and cardiovascular effects?]. Praxis (Bern 1994). 2005;94:1851–1858.
   PubMedGoogle Scholar
• Zeng C, Sun H, Xie P, et al. The role of apoptosis in MCLR-induced developmental toxicity in zebrafish embryos. Aquat Toxicol (Amsterdam, Netherlands). 2014;149:25–32.
   PubMed Web of Science ®Google Scholar
• Kane AS, Salierno JD, Gipson GT, et al. A video-based movement analysis system to quantify behavioral stress responses of fish. Water Res. 2004;38:3993–4001.
   PubMed Web of Science ®Google Scholar
• Si J, Zhou R, Song J, et al. Toxic effects of (56)Fe ion radiation on the zebrafish (Danio rerio) embryonic development. Aquat Toxicol (Amsterdam, Netherlands). 2017;186:87–95.
   PubMed Web of Science ®Google Scholar
• Raftery TD, Volz DC. Abamectin induces rapid and reversible hypoactivity within early zebrafish embryos. Neurotoxicol Teratol. 2015;49:10–18.
   PubMed Web of Science ®Google Scholar
• Wang ZG, Zhou R, Jiang D, et al. Toxicity of graphene quantum dots in zebrafish embryo. Biomed Environ Sci. 2015;28:341–351.
   PubMed Web of Science ®Google Scholar
• Steenbergen PJ, Richardson MK, Champagne DL. The use of the zebrafish model in stress research. Prog Neuro-Psychopharmacol Biol Psychiatry. 2011;35:1432–1451.
   PubMed Web of Science ®Google Scholar
• Zhang T, Xu L, Wu JJ, et al. Transcriptional responses and mechanisms of copper-induced dysfunctional locomotor behavior in zebrafish embryos. Toxicol Sci. 2015;148:299–310.
   PubMed Web of Science ®Google Scholar
• Verma R, Singh A, Jaiswal R, et al. Association of Ki-67 antigen and p53 protein at invasive tumor front of oral squamous cell carcinoma. Indian J Pathol Microbiol. 2014;57:553–557.
   PubMed Web of Science ®Google Scholar
• Cerignoli F, Abassi YA, Lamarche BJ, et al. In vitro immunotherapy potency assays using real-time cell analysis. PloS one. 2018;13:e0193498.
   PubMed Web of Science ®Google Scholar
• Gong H, Zolzer F, von Recklinghausen G, et al. Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis. Leukemia. 2000;14:826–829.
   PubMed Web of Science ®Google Scholar
• Yu T, Wu Y, Helman JI, et al. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway. Mol Cancer Res MCR. 2011;9:161–172.
   PubMed Web of Science ®Google Scholar
• Gallo O, Masini E, Bianchi B, et al. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Human Pathol. 2002;33:708–714.
   PubMed Web of Science ®Google Scholar
• Zou C, Zhang H, Li Q, et al. Heme oxygenase-1: a molecular brake on hepatocellular carcinoma cell migration. Carcinogenesis 2011;32:1840–1848.
   PubMed Web of Science ®Google Scholar
• Stein U, Arlt F, Smith J, et al. Intervening in beta-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis. Neoplasia (New York, N.Y.). 2011;13:131–144.
   PubMed Web of Science ®Google Scholar
• Pyatrikas DV, Fedoseeva IV, Varakina NN, et al. Relation between cell death progression, reactive oxygen species production and mitochondrial membrane potential in fermenting Saccharomyces cerevisiae cells under heat-shock conditions. FEMS Microbiol Lett. 2015;362:fnv082.
   PubMed Web of Science ®Google Scholar
• Wang JP, Hsieh CH, Liu CY, et al. Reactive oxygen species-driven mitochondrial injury induces apoptosis by teroxirone in human non-small cell lung cancer cells. Oncol Lett. 2017;14:3503–3509.
   PubMed Web of Science ®Google Scholar
• Bazhin AV, Philippov PP, Karakhanova S. Reactive oxygen species in cancer biology and anticancer therapy. Oxid Med Cell Longevity. 2016;2016:1.
   Web of Science ®Google Scholar
• Mathur A, Hong Y, Kemp BK, et al. Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovasc Res. 2000;46:126–138.
   PubMed Web of Science ®Google Scholar